These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16857251)

  • 41. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking.
    Bossert JM; Gray SM; Lu L; Shaham Y
    Neuropsychopharmacology; 2006 Oct; 31(10):2197-209. PubMed ID: 16341024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociation of mGlu2/3 agonist effects on ketamine-induced regional and event-related oxygen signals.
    Francois J; Gastambide F; Conway MW; Tricklebank M; Gilmour G
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4219-29. PubMed ID: 25943169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist.
    Wischhof L; Hollensteiner KJ; Koch M
    Behav Pharmacol; 2011 Dec; 22(8):805-13. PubMed ID: 22015807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.
    Orlando R; Borro M; Motolese M; Molinaro G; Scaccianoce S; Caruso A; di Nuzzo L; Caraci F; Matrisciano F; Pittaluga A; Mairesse J; Simmaco M; Nisticò R; Monn JA; Nicoletti F
    Neuropharmacology; 2014 Nov; 86():133-44. PubMed ID: 25063582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
    Rorick-Kehn LM; Johnson BG; Knitowski KM; Salhoff CR; Witkin JM; Perry KW; Griffey KI; Tizzano JP; Monn JA; McKinzie DL; Schoepp DD
    Psychopharmacology (Berl); 2007 Jul; 193(1):121-36. PubMed ID: 17384937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
    Imre G
    CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretreatment with mGluR2 or mGluR3 Agonists Reduces Apoptosis Induced by Hypoxia-Ischemia in Neonatal Rat Brains.
    Bratek-Gerej E; Bronisz A; Ziembowicz A; Salinska E
    Oxid Med Cell Longev; 2021; 2021():8848015. PubMed ID: 33763176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.
    Sutton LP; Rushlow WJ
    J Neurochem; 2011 Jun; 117(6):973-83. PubMed ID: 21477044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabotropic glutamate receptors regulate cortical gamma hyperactivities elicited by ketamine in rats.
    Hiyoshi T; Hikichi H; Karasawa J; Chaki S
    Neurosci Lett; 2014 May; 567():30-4. PubMed ID: 24680852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.
    Xing B; Han G; Wang MJ; Snyder MA; Gao WJ
    Neuropharmacology; 2018 Jul; 137():359-371. PubMed ID: 29793154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.
    Cartmell J; Monn JA; Schoepp DD
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):39-46. PubMed ID: 10651145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.
    Karkhanis AN; Beveridge TJ; Blough BE; Jones SR; Ferris MJ
    Drug Alcohol Depend; 2016 Sep; 166():51-60. PubMed ID: 27394931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.
    Chan MH; Tsai YL; Lee MY; Stoker AK; Markou A; Chen HH
    Psychopharmacology (Berl); 2015 Sep; 232(17):3259-68. PubMed ID: 26044619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression.
    Wischhof L; Koch M
    Psychopharmacology (Berl); 2012 Jan; 219(2):387-400. PubMed ID: 21863235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of aberrant gamma frequency oscillations on prepulse inhibition.
    Jones NC; Anderson P; Rind G; Sullivan C; van den Buuse M; O'Brien TJ
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1671-81. PubMed ID: 24832766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. mGluR2/3 agonist LY379268, by enhancing the production of GDNF, induces a time-related phosphorylation of RET receptor and intracellular signaling Erk1/2 in mouse striatum.
    Di Liberto V; Mudò G; Belluardo N
    Neuropharmacology; 2011 Sep; 61(4):638-45. PubMed ID: 21619889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.
    Bäckström P; Hyytiä P
    Eur J Pharmacol; 2005 Dec; 528(1-3):110-8. PubMed ID: 16324694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.